Lillia, an AI startup, has launched a platform to help manage diabetes and related chronic conditions using AI and expert ...

Health2Sync Deepens Reach and Partnerships in South Korea with Growing Adoption of its Digital Disease Management Platform ...

The Medicines and Healthcare Products Regulatory Agency (MHRA) revealed in association with the use of GLP-1RA receptor ...

Receptors on B and T cells hint at what the immune system is targeting. An AI approach called Mal-ID developed increases diagnostic accuracy, particularly for autoimmune diseases.

More people are using wearable glucose monitors as the appetite for personalized health data grows beyond smartwatches and fitness trackers. For years, people with diabetes have used continuous ...

These findings support the claim that Medicare Advantage (MA) payments may be driven more by diagnosis and coding practices ...

MarketWatch was able to verify Zeng's claims via videos and was also able to order delivery of Ozempic to an address in China. The price was 798 yuan ($108) for a one-month supply that is injected ...

More education and sensitisation on the management of diabetics must be carried out to put the minds of patients at ...

Researchers at The University of Colorado Anschutz Medical Campus and colleagues at Massachusetts General Hospital, have ...

Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have ...

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of obesity ...